Publication | Closed Access

Possibility of ideal blood glucose control by a new oral hypoglycemic agent, N-[(trans-4-isopropylcyclohexyl)-carbonyl]-d-phenylalanine (A-4166), and its stimulatory effect on insulin secretion in animals

Metabolic SyndromeDiabetes ManagementStimulatory EffectMedicineInsulin ManagementDiabetesPhysiologyBlood Glucose MonitoringEndocrinologyInsulin SecretionHyperglycemiaIdeal BloodMetabolismPharmacologyInsulin SignalingHealth Sciences